Neutralizing IL-1β antibodies reduced the bacterial burden and pulmonary inflammation induced by Pseudomonas aeruginosa in cystic fibrosis rodents and enhanced IL-1β activation upon exposure to Pseudomonas aeruginosa [203]. This evidence concerns the gene IL1B and cystic fibrosis.